Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients.

被引：0
|
作者：
Benhamou, Y
Piketty, C
Katlama, C
Rozembaum, W
Neau, D
Lafeuillade, A
Rey, D
Yazdanpanah, Y
Trimoulet, P
Fleury, H
机构：
[1] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[2] Hop Georges Pompidou, Paris, France
[3] Hop Tenon, F-75970 Paris, France
[4] Hop Pellegrin, F-33076 Bordeaux, France
[5] Hop Chalucet, Toulon, France
[6] Hop Tourcoing, Strasbourg, France
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1155
引用
收藏
页码：712A / 713A
页数：2
相关论文
共 50 条
  • [31] The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients - Reply
    Clumeck, N
    JOURNAL OF HEPATOLOGY, 2005, 43 (02) : 361 - 361
  • [32] Low rate of delayed response in lamivudine experienced HIV/HBV co-infected patients treated with tenofovir disoproxil fumarate (TDF)
    Lada, O.
    Gervais, A.
    Branger, M.
    Peytavin, G.
    Colin, G.
    Fraqueiro, G.
    Males, S.
    Martinot-Peignoux, M.
    Matheron, S.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S259 - S259
  • [33] Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus
    Chen, Huey-Ling
    Lee, Chien-Nan
    Chang, Chin-Hao
    Ni, Yen-Hsuan
    Shyu, Ming-Kwang
    Chen, Shih-Ming
    Hu, Jen-Jan
    Lin, Hans Hsienhong
    Zhao, Lu-Lu
    Mu, Shu-Chi
    Lai, Ming-Wei
    Lee, Chyi-Long
    Lin, Hsien-Ming
    Tsai, Ming-Song
    Hsu, Jenn-Jeih
    Chen, Ding-Shinn
    Chan, K. Arnold
    Chang, Mei-Hwei
    HEPATOLOGY, 2015, 62 (02) : 375 - 386
  • [34] REAL-WORLD CLINICAL AND VIROLOGICAL OUTCOMES OF UNTREATED AND TENOFOVIR DISOPROXIL FUMARATE (TDF)-TREATED CHRONIC HEPATITIS B (CHB) PREGNANT PATIENTS IN A LOW HEPATITIS B VIRUS (HBV) ENDEMIC REGION
    Kochaksaraei, Golasa Samadi
    Shaheen, Abdel Aziz
    Castillo, Eliana
    Martin, Steven R.
    Israelson, Heidi
    Aspinall, Alex
    Borman, Meredith A.
    Congly, Stephen E.
    Stinton, Laura M.
    Lee, Samuel S.
    Coffin, Carla S.
    HEPATOLOGY, 2019, 70 : 600A - 601A
  • [35] Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir
    Pruvost, Alain
    Negredo, Eugenia
    Theodoro, Frederic
    Puig, Jordi
    Levi, Mikael
    Ayen, Rafaela
    Grassi, Jacques
    Clotet, Bonaventura
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1937 - 1943
  • [36] Early switching of tenofovir disoproxil fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective study
    Patamatamkul, Samadhi
    Songumpai, Nopporn
    Payoong, Paruspak
    Katavetin, Pisut
    Putcharoen, Opass
    HIV RESEARCH & CLINICAL PRACTICE, 2022, 23 (01) : 99 - 106
  • [37] Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China
    Wu, Ya-Song
    Zhang, Wei-Wei
    Ling, Xue-Mei
    Yang, Lian
    Huang, Shao-Biao
    Wang, Xi-Cheng
    Wu, Hao
    Cai, Wei-Ping
    Wang, Min
    Wang, Hui
    Liu, Yan-Fen
    He, Hao-Lan
    Wei, Fei-Li
    Wu, Zun-You
    Zhang, Fu-Jie
    CHINESE MEDICAL JOURNAL, 2016, 129 (03) : 304 - 308
  • [38] Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China
    Wu Ya-Song
    Zhang Wei-Wei
    Ling Xue-Mei
    Yang Lian
    Huang Shao-Biao
    Wang Xi-Cheng
    Wu Hao
    Cai Wei-Ping
    Wang Min
    Wang Hui
    Liu Yan-Fen
    He Hao-Lan
    Wei Fei-Li
    Wu Zun-You
    Zhang Fu-Jie
    中华医学杂志英文版, 2016, 129 (03) : 304 - 308
  • [39] Safety and efficacy at 1 year after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide in patients with chronic hepatitis B and risk factors for TDF use
    Gane, E.
    Seto, W. K.
    Janssen, H.
    Caruntu, F. A.
    Kim, H. J.
    Abdurakhmanov, D.
    Nishiguchi, S.
    Andrzej, H.
    Bae, H.
    Mo, S.
    Suri, V.
    Gaggar, A.
    Flaherty, J. F.
    Kao, J-H
    Brunetto, M.
    Buti Ferret, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 42 - 43
  • [40] Evaluation of serum HBV RNA and HBcrAg in chronic hepatitis B patients achieving different serological outcomes on tenofovir disoproxil fumarate (TDF)
    Cathcart, A. L.
    Buti, M.
    Marcellin, P.
    Gaggar, A.
    Delaney, W.
    Kitrinos, K. M.
    van Bommel, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S476 - S476
12345